• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trial Listings
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Store » May 2005 – The CenterWatch Monthly : PDF
May 2005 – The CenterWatch Monthly : PDF

May 2005 – The CenterWatch Monthly : PDF

$79.00

Product Details

US Sites Rate Eli Lilly, Wyeth and Genentech as Top Sponsors in 2005

Results of the 2005 Thomson CenterWatch U.S. Report Card Survey are in. Sites have rated Eli Lilly one of the top sponsors to work with for the third time in eight years. Wyeth has shown dramatic improvement after occupying the lower ranks for several years. Amgen and Genentech’s rankings illustrate the growing influence of the biotech firms as they continue to increase their clinical development efforts.

UNC, Quintiles Move Beyond Central Trial Office

A newly forged agreement between the University of North Carolina (UNC), an academic health center, and Quintiles, a contract research organization, will create an on-campus clinical trial unit targeting new faculty who are interested in pursuing industry-funded studies but lack the infrastructure to get started. Quintiles is putting up $600,000 over two years to help UNC hire needed administrative and clinical staff. The partnership is expected to bring UNC additional opportunities to participate in industry-sponsored trials and at the same time to bring Quintiles opportunities to participate in NIH grant proposals.

The Vienna School of Clinical Research: Filling the Training Gap

The Vienna School of Clinical Research continues the city of Vienna’s long tradition of playing a major role in medical science by promoting the training of clinical researchers.

Eye on: Multiple Sclerosis

Multiple Sclerosis affects two million patients worldwide. CenterWatch has identified a pipeline of 17 drugs in development for MS.
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing